Soleno Therapeutics (SLNO) Change in Account Payables (2013 - 2026)
Soleno Therapeutics (SLNO) reported Change in Account Payables of -$3.0 million for Q1 2026, up 10.97% year-over-year from -$2.7 million in Q1 2025, and down 169.3% on a QoQ basis from $4.3 million in Q4 2025.
Soleno Therapeutics (SLNO) has 14 years of Change in Account Payables data on file, last reported at -$3.0 million in Q1 2026.
- Quarterly Change in Account Payables rose 10.97% year-over-year to -$3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 257.3% YoY) and the FY2025 annual result came in at $3.6 million, down 36.32% from the prior year.
- Change in Account Payables declined to -$3.0 million in Q1 2026 per SLNO's latest filing, from $4.3 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $4.9 million in Q1 2024 and bottomed at -$4.3 million in Q2 2024.
- The 5-year median for Change in Account Payables is $198000.0 (2022), against an average of $365235.3.
- Peak annual rise in Change in Account Payables reached 7482.35% in 2024, while the deepest fall reached 733.92% in 2024.
- Tracing SLNO's Change in Account Payables over 5 years: stood at -$547000.0 in 2022, then soared by 106.22% to $34000.0 in 2023, then soared by 7482.35% to $2.6 million in 2024, then surged by 66.25% to $4.3 million in 2025, then sank by 169.3% to -$3.0 million in 2026.
- Per Business Quant, the three latest SLNO Change in Account Payables figures stand at -$3.0 million (Q1 2026), $4.3 million (Q4 2025), and $1.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | -2.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.97 Mn |
| Mar 31, 2026 | -2.97 Mn |
| Dec 31, 2025 | 4.29 Mn |
| Dec 31, 2025 | 4.29 Mn |
| Sep 30, 2025 | 1.93 Mn |
| Sep 30, 2025 | 1.93 Mn |
| Jun 30, 2025 | 733,000.00 |
| Jun 30, 2025 | 733,000.00 |
| Mar 31, 2025 | -3.34 Mn |
| Mar 31, 2025 | -3.34 Mn |
| Dec 31, 2024 | 2.58 Mn |
| Dec 31, 2024 | 2.58 Mn |
| Sep 30, 2024 | 2.53 Mn |
| Sep 30, 2024 | 2.53 Mn |
| Jun 30, 2024 | -4.30 Mn |
| Jun 30, 2024 | -4.30 Mn |
| Mar 31, 2024 | 4.87 Mn |
| Mar 31, 2024 | 4.87 Mn |
| Dec 31, 2023 | 34,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Sep 30, 2023 | -341,000.00 |
| Sep 30, 2023 | -341,000.00 |
| Jun 30, 2023 | 678,000.00 |
| Jun 30, 2023 | 678,000.00 |
| Mar 31, 2023 | 1.00 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | -547,000.00 |
| Dec 31, 2022 | -547,000.00 |
| Sep 30, 2022 | -82,000.00 |
| Sep 30, 2022 | -82,000.00 |
| Jun 30, 2022 | 198,000.00 |
| Jun 30, 2022 | 198,000.00 |
| Mar 31, 2022 | -1.05 Mn |
| Mar 31, 2022 | -1.05 Mn |
| Dec 31, 2021 | 134,000.00 |
| Dec 31, 2021 | 134,000.00 |
| Sep 30, 2021 | -216,000.00 |
| Sep 30, 2021 | -216,000.00 |
| Jun 30, 2021 | -1.33 Mn |
| Jun 30, 2021 | -1.33 Mn |
| Mar 31, 2021 | 1.18 Mn |
| Mar 31, 2021 | 1.18 Mn |
| Dec 31, 2020 | 279,000.00 |
| Dec 31, 2020 | 279,000.00 |
| Sep 30, 2020 | -404,000.00 |
| Sep 30, 2020 | -404,000.00 |
| Jun 30, 2020 | 134,000.00 |
| Jun 30, 2020 | 134,000.00 |
| Mar 31, 2020 | 1.49 Mn |
| Mar 31, 2020 | 1.49 Mn |
| Dec 31, 2019 | 260,000.00 |
| Dec 31, 2019 | 260,000.00 |
| Sep 30, 2019 | -5,000.00 |
| Sep 30, 2019 | -5,000.00 |
| Jun 30, 2019 | 482,000.00 |
| Jun 30, 2019 | 482,000.00 |
| Mar 31, 2019 | 324,000.00 |
| Mar 31, 2019 | 324,000.00 |
| Dec 31, 2018 | -363,000.00 |
| Dec 31, 2018 | -363,000.00 |
| Sep 30, 2018 | 264,000.00 |
| Sep 30, 2018 | 264,000.00 |
| Jun 30, 2018 | -61,000.00 |
| Jun 30, 2018 | -61,000.00 |
| Mar 31, 2018 | 409,000.00 |
| Mar 31, 2018 | 409,000.00 |
| Dec 31, 2017 | -41,000.00 |
| Dec 31, 2017 | -41,000.00 |
| Sep 30, 2017 | 273,000.00 |
| Sep 30, 2017 | 273,000.00 |
| Jun 30, 2017 | 163,000.00 |
| Jun 30, 2017 | 163,000.00 |
| Mar 31, 2017 | -204,000.00 |
| Mar 31, 2017 | -204,000.00 |
| Dec 31, 2016 | -412,828.00 |
| Dec 31, 2016 | -412,828.00 |
| Sep 30, 2016 | 258,000.00 |
| Sep 30, 2016 | 258,000.00 |
| Jun 30, 2016 | -549,000.00 |
| Jun 30, 2016 | -549,000.00 |
| Mar 31, 2016 | 627,000.00 |
| Mar 31, 2016 | 627,000.00 |
| Dec 31, 2015 | -330,055.00 |
| Dec 31, 2015 | -330,055.00 |
| Sep 30, 2015 | 141,000.00 |
| Sep 30, 2015 | 141,000.00 |
| Jun 30, 2015 | 202,000.00 |
| Jun 30, 2015 | 202,000.00 |
| Mar 31, 2015 | 199,000.00 |
| Mar 31, 2015 | 199,000.00 |
| Dec 31, 2014 | 250,897.00 |
| Dec 31, 2014 | 250,897.00 |
| Sep 30, 2014 | -115,000.00 |
| Sep 30, 2014 | -115,000.00 |
| Jun 30, 2014 | 187,000.00 |
| Jun 30, 2014 | 187,000.00 |
| Mar 31, 2014 | 31,000.00 |
| Mar 31, 2014 | 31,000.00 |
| Dec 31, 2013 | -55,803.00 |
| Dec 31, 2013 | -55,803.00 |